Rare Diseases that People Suffer From

In working towards finding a drug that could control or eradicate Alzheimer’s, the NIH has been able to launch a portal for research on potential drugs. It supported research and experiments done on mice to test whether cancer drugs could restore brain functioning. Studies have determined that versatile proteins should be the new targets for Alzheimer’s drugs. More research has been done to see the effect that allergy drugs have the disease and also on how drugs activate brain stem cells may reverse multiple sclerosis.
On the 4th of March 2015 the NIH in conjunction with the National Institute on Aging (NIA), the Food and Drug Administration (FDA) industry, and academic scientists from other research organizations launched the data portal for Alzheimer’s drug in order to hasten the process of drug development. The opening of the portal is expected to make it easier for researchers and scientists studying the disease to be able to compare their findings and analyze other datasets. The researchers believe that this move will make it easier to develop predictive models of the disease and know the factors that lead to the development of the various signs and symptoms. The aim of the portal is to have a transparent, productive and reliable platform where different scientists and researchers can put their work and compare with the works of other scientists as they all work towards the goal of finding a drug for Alzheimer’s disease.
According to Francis S. Collins, the NIH Director, the launch of the portal will enable the researchers to save time and money as well as come up with new diagnostics and effective therapies for the disease. He also says the aim of the portal was to employ open science is revolutionizing research and drug development process.